March 4, 2026 Acuitas Therapeutics Named Top 100 Global Innovator by LexisNexis for 2026 Read about Acuitas Therapeutics Named Top 100 Global Innovator by LexisNexis for 2026
February 23, 2026 Acuitas Therapeutics Announces Oral Presentations and Poster Sessions at BioChina and Vaccine Innovation Forum Read about Acuitas Therapeutics Announces Oral Presentations and Poster Sessions at BioChina and Vaccine Innovation Forum
February 10, 2026 Acuitas Therapeutics Named One of BC’s Top Employers Read about Acuitas Therapeutics Named One of BC’s Top Employers
January 20, 2026 Dr. Ying Tam and Sean Semple Share the New Frontier of Lipid Nanoparticles in mRNA Cancer Vaccines in the European Biopharmaceutical Review Read about Dr. Ying Tam and Sean Semple Share the New Frontier of Lipid Nanoparticles in mRNA Cancer Vaccines in the European Biopharmaceutical Review
January 8, 2026 Acuitas Therapeutics Expands Collaboration with RNA Technologies & Therapeutics Through Strategic Investment Read about Acuitas Therapeutics Expands Collaboration with RNA Technologies & Therapeutics Through Strategic Investment
December 1, 2025 Acuitas Therapeutics and partners publish comparative study of AAV and mRNA-LNP delivery with in situ sequencing for spatial genome editing Read about Acuitas Therapeutics and partners publish comparative study of AAV and mRNA-LNP delivery with in situ sequencing for spatial genome editing
November 17, 2025 Acuitas Therapeutics unveils next-generation lipid nanoparticle advancements at the 2025 mRNA Health Conference Read about Acuitas Therapeutics unveils next-generation lipid nanoparticle advancements at the 2025 mRNA Health Conference
October 29, 2025 Acuitas Therapeutics to showcase LNP delivery platform at four prestigious conferences in November 2025 Read about Acuitas Therapeutics to showcase LNP delivery platform at four prestigious conferences in November 2025
October 6, 2025 Business in Vancouver shines a spotlight on Acuitas Therapeutics in its Life Sciences 2025 feature Read about Business in Vancouver shines a spotlight on Acuitas Therapeutics in its Life Sciences 2025 feature
September 4, 2025 Acuitas Therapeutics and collaborators demonstrate strong protection against P. vivax malaria with mRNA-LNP vaccine Read about Acuitas Therapeutics and collaborators demonstrate strong protection against P. vivax malaria with mRNA-LNP vaccine
September 2, 2025 Acuitas Therapeutics announces oral presentations at the 2025 Alliance for mRNA Medicines’ Annual Meeting Read about Acuitas Therapeutics announces oral presentations at the 2025 Alliance for mRNA Medicines’ Annual Meeting
August 19, 2025 Acuitas Therapeutics contributes to new insights into broadly neutralizing antibodies induced by COVID-19 mRNA vaccines Read about Acuitas Therapeutics contributes to new insights into broadly neutralizing antibodies induced by COVID-19 mRNA vaccines